findmyKOL
Clinical trialNCT05659381RecruitingPhase 3Interventional

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

SponsorGOG FoundationEnrollment220Stage III Fallopian Tube CancerStage III Ovarian CancerStage III Primary Peritoneal CancerStage IV Fallopian Tube CancerStage IV Ovarian CancerStage IV Primary Peritoneal Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

Patients will be registered prior to, during or at the completion of neoadjuvant chemotherapy given per standard institutional guidelines +/- bevacizumab on Day 1 every 21 days for 3-4 cycles. Registered patients who progress during neoadjuvant chemotherapy will not be eligible for iCRS and will be removed from the study. Following completion of neoadjuvant chemotherapy, interval cytoreductive surgery (iCRS) will be performed in the usual fashion in both arms. Patients will be randomized at the time of iCRS (iCRS must achieve no gross residual disease or no disease \>1.0 cm in largest diameter) to receive HIPEC or no HIPEC. Patients randomized to HIPEC Arm will receive a single dose of cisplatin (100mg/m2 IP over 90 minutes at 42 C) as HIPEC. After postoperative recovery patients will receive standard post-operative platinum-based combination chemotherapy. Patients randomized to surgery only (No HIPEC Arm) will receive postoperative standard chemotherapy after recovery from surgery. Both groups will receive an additional 2-3 cycles of platinum-based combination chemotherapy per standard institutional guidelines +/- bevacizumab for a maximum total of 6 cycles of chemotherapy (neoadjuvant plus post-operative cycles) followed by niraparib individualized dosing +/- bevacizumab until progression or 36 months (if no evidence of disease).

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

59 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • City of Hope

    Duarte, California, United States

    Thanh Dellinger, MD
    Recruiting
  • University of California San Diego Moores Cancer Center

    La Jolla, California, United States

    Michael McHale, MD
    Recruiting
  • Hoag Memorial Hospital Presbyterian

    Newport Beach, California, United States

    Alberto Mendivil, MD
    Recruiting
  • Stanford Ambulatory Surgery Center Lane Operating Room

    Palo Alto, California, United States

    Amer Karam, MD
    Recruiting
  • Stanford Hospital

    Palo Alto, California, United States

    Amer Karam, MD
    Recruiting
  • Stanford Women'S Cancer Center

    Palo Alto, California, United States

    Amer Karam, MD
    Recruiting
  • University of Colorado Hospital - Anshutz Cancer Pavilion

    Aurora, Colorado, United States

    Lindsay J Wheeler Brubaker, MD
    Recruiting
  • Hartford Hospital

    Hartford, Connecticut, United States

    Amy Brown, MD
    Recruiting
  • Smilow Cancer Hospital at Yale- New Haven

    New Haven, Connecticut, United States

    Vaagn Andikyan, MD
    Recruiting
  • Yale University School of Medicine

    New Haven, Connecticut, United States

    Elena Ratner, MD
    Recruiting
  • Sylvester Comprehensive Cancer Center - the Lennar Foundation Medical Center

    Coral Gables, Florida, United States

    Abdulrahman K Sinno, MD
    Recruiting
  • University of Miami Hospital and Clinics - Deerfield Beach

    Deerfield Beach, Florida, United States

    Abdulrahman Sinno, MD
    Recruiting
  • Miami Cancer Institute

    Miami, Florida, United States

    John Diaz, MD
    Recruiting
  • University of Miami Hospital and Clinics

    Miami, Florida, United States

    Abdulrahman Sinno, MD
    Recruiting
  • Sylvester Comprehensive Cancer Center - Plantation

    Plantation, Florida, United States

    Abdulrahman Sinno, MD
    Recruiting
  • University of Kansas Hospital

    Kansas City, Kansas, United States

    Andrea Jewell, MD
    Recruiting
  • University of Kansas Medical Center Mob

    Kansas City, Kansas, United States

    Andrea Jewell, MD
    Recruiting
  • University of Kansas Cancer Center Overland Park

    Overland Park, Kansas, United States

    Andrea Jewell, MD
    Recruiting
  • University of Kansas Indian Creek Breast Surgery

    Overland Park, Kansas, United States

    Andrea Jewell, MD
    Recruiting
  • University of Kansas Cancer Center Westwood

    Westwood, Kansas, United States

    Andrea Jewell, MD
    Recruiting
  • University of Kansas Clinical Research Center

    Westwood, Kansas, United States

    Andrea Jewell, MD
    Recruiting
  • University of Kentucky Medical Center

    Lexington, Kentucky, United States

    Charles Dietrich, MD
    Recruiting
  • Lsu Health New Orleans

    New Orleans, Louisiana, United States

    Amelia Jernigan, MD
    Recruiting
  • University Medical Center New Orleans

    New Orleans, Louisiana, United States

    Amelia Jernigan, MD
    Recruiting
  • Mayo Clinic

    Rochester, Minnesota, United States

    Carrie Langstraat, MD
    Recruiting
  • University of Kansas Cancer Center

    Kansas City, Missouri, United States

    Andrea Jewell, MD
    Recruiting
  • University of Kansas Cancer Center North

    Kansas City, Missouri, United States

    Andrea Jewell, MD
    Recruiting
  • University of Kansas Cancer Center Lee'S Summit

    Lee's Summit, Missouri, United States

    Andrea Jewell, MD
    Recruiting
  • Washington University School of Medicine

    St Louis, Missouri, United States

    Premal Thaker, MD
    Recruiting
  • Holy Name Medical Center

    Teaneck, New Jersey, United States

    Sharyn Lewin
    Recruiting
  • University of New Mexico Comprehensive Cancer Center

    Albuquerque, New Mexico, United States

    Carolyn Muller, MD
    Recruiting
  • Memorial Sloan-Kettering Cancer Center

    New York, New York, United States

    Dennis Chi, MD
    Recruiting
  • Duke Cancer Center

    Durham, North Carolina, United States

    Jennifer L McNally, MD
    Recruiting
  • Duke Women'S Cancer Care Raleigh

    Raleigh, North Carolina, United States

    Jennifer L McNally, MD
    Recruiting
  • Uh Geauga Medical Center

    Chardon, Ohio, United States

    Sarah Lynam, MD
    Recruiting
  • Trihealth Cancer Institute - Good Samaritan Hospital

    Cincinnati, Ohio, United States

    Robert Neff, MD
    Recruiting
  • Trihealth Cancer Institute- Thomas Comprehensive Care Center

    Cincinnati, Ohio, United States

    Robert Neff, MD
    Recruiting
  • University of Cincinnati Medical Center

    Cincinnati, Ohio, United States

    Caroline Billingsley, MD
    Recruiting
  • Cleveland Clinic

    Cleveland, Ohio, United States

    Robert Debernardo Jr., MD
    Recruiting
  • University Hospitals Cleveland Medical Center

    Cleveland, Ohio, United States

    Sarah Lynam, MD
    Recruiting
19 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
8 Mar 2024
Primary completion
1 Aug 2029
Completion
1 Aug 2034
Last update posted
16 Apr 2026
Registered enrollment
220
Registry id
NCT05659381

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.